Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Dec 06, 2023 10:42am
70 Views
Post# 35770925

RE:0.14c coming soon don't fall for this charade

RE:0.14c coming soon don't fall for this charadeAgree!...feels like sentiment is shifting in our favour...let's see this ANVISA approval/partnership reveal...let's hear the name of our partner on epidiolex generic ....let's not forget GW was sued by canopy for patent infringement on CBD (epidiolex)...suit was dismissed....no way GW(JAZZ wins) patent case against would be generics...could be dismissed anyday..and management better not be thinking of bringing an all equity M&A at this share price..3m of additional annualized savings beginning this quarter..everything's moving towards profitability...time for this to level up in a big way...only Canadian Corp with D.E.L for cannabinoids and FDA site audit.. as mentioned U.S rescheduling imminent openeing the flood gates for mass large scale research and API demand...feels like trains about to leave station...I bet we see this 2m bid at .06 move up soon.
<< Previous
Bullboard Posts
Next >>